Bio & Health Archives | Page 3 of 23 | Be Korea-savvy

Archive by category Bio & Health

SK Bioscience Deepens Ties With Gates Foundation on Pandemic Preparedness

SK Bioscience Deepens Ties With Gates Foundation on Pandemic Preparedness

SEOUL, Aug. 21 (Korea Bizwire) — SK bioscience Co., the biotech arm of South Korea’s SK Group, said Thursday it will expand cooperation with the Gates Foundation on next-generation preventive medicines, with a focus on research and development (R&D) for pandemic preparedness. Officials from SK bioscience and the foundation held a meeting in Seoul on [...]

South Korea Launches First Nationwide Organoid Consortium to Boost Global Competitiveness

South Korea Launches First Nationwide Organoid Consortium to Boost Global Competitiveness

SEOUL, Aug. 13 (Korea Bizwire) — South Korea has established its first national body dedicated to advancing organoid technology, marking a significant step toward standardizing and commercializing the field amid growing global demand for alternatives to animal testing. The K-Organoid Consortium, officially launched on August 13 at The Westin Josun Seoul, brings together 27 companies [...]

LG Deepens Bet on Biotech with Stake in U.S. Cancer Therapy Firm

LG Deepens Bet on Biotech with Stake in U.S. Cancer Therapy Firm

SEOUL, August 3 (Korea Bizwire) — LG Group is ramping up its investments in the biotech sector, acquiring a stake in U.S.-based cancer therapy developer Strand Therapeutics as part of a broader push into future-growth industries. Strand Therapeutics, headquartered in Cambridge, Massachusetts, is a messenger RNA (mRNA) therapeutics company founded in 2017 by bioengineering graduates [...]

Samsung Biologics Q2 Net Profit Up 2 Pct On Output Expansion

Samsung Biologics Q2 Net Profit Up 2 Pct On Output Expansion

SEOUL, July 23 (Korea Bizwire) — Samsung Biologics Co. said Wednesday its second-quarter net profit gained slightly on-year, backed by increased production output at its latest facilities. Samsung Biologics’ net profit for the April-June period gained 2 percent on-year to 324.4 billion won (US$235.1 million), the company said in a regulatory filing. Operating profit rose [...]

New Public Health Chief Prioritizes mRNA Vaccines, Climate Resilience

New Public Health Chief Prioritizes mRNA Vaccines, Climate Resilience

SEOUL, July 16 (Korea Bizwire) — Im Seung-kwan, newly appointed as the fourth Commissioner of the Korea Disease Control and Prevention Agency (KDCA), pledged Monday to strengthen South Korea’s public health security infrastructure and position the agency as a central command hub for infectious disease crises. Speaking at his inauguration ceremony at KDCA headquarters in Osong, [...]

Gov’t Support Needed To Offset Risks From Trump’s Drug Tariffs: Think Tank

Gov’t Support Needed To Offset Risks From Trump’s Drug Tariffs: Think Tank

SEOUL, July 15 (Korea Bizwire) — South Korea’s pharmaceuticals industry needs government-level support to mitigate potential impacts from the United States’ aggressive tariff policies, a local think tank said Tuesday. The recommendation comes after U.S. President Donald Trump threatened to impose tariffs of up to 200 percent on foreign-made pharmaceuticals as part of his protectionist [...]

Health Supplements Outpace Biohealth Sector Amid Economic Slowdown

Health Supplements Outpace Biohealth Sector Amid Economic Slowdown

SEOUL, July 15 (Korea Bizwire)  — Despite a sluggish economy, South Korea’s health supplement industry posted double-digit growth in 2023, becoming the only segment of the country’s biohealth sector to do so, according to new government data. A report released July 13 by the Korea Health Industry Development Institute (KHIDI) showed that the health supplement [...]

South Korea to Fast-Track Biosimilar Approvals Starting Next Year

South Korea to Fast-Track Biosimilar Approvals Starting Next Year

  SEOUL, July 14 (Korea Bizwire) — In a move expected to accelerate the rollout of biosimilars — often referred to as a next-generation growth engine — South Korea’s drug regulator plans to streamline the approval process for these cost-effective biologic drugs beginning in 2026. According to pharmaceutical industry sources on Sunday, the Ministry of Food [...]

Pharmaceutical Industry Faces Renewed Scrutiny Over Illegal Rebates Amid Structural Challenges

Pharmaceutical Industry Faces Renewed Scrutiny Over Illegal Rebates Amid Structural Challenges

SEOUL, July 8 (Korea Bizwire) — South Korea’s pharmaceutical industry is once again under fire as a string of illegal rebate scandals have surfaced in 2025, reigniting calls for structural reform and stronger support for new drug development. Prosecutors recently indicted three mid-sized pharmaceutical companies and their employees in connection with the so-called “residents’ rebate” [...]